RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,140.00
-10.00 (-0.16%)
At close: May 8, 2026
Market Cap50.96B +12.2%
Revenue (ttm)136.22B +9.9%
Net Income4.68B
EPS541.00
Shares Out8.67M
PE Ratio10.87
Forward PEn/a
Dividend50.00 (0.81%)
Ex-Dividend DateDec 29, 2025
Volume11,770
Average Volume14,463
Open6,150.00
Previous Close6,150.00
Day's Range6,000.00 - 6,190.00
52-Week Range5,480.00 - 9,130.00
Beta0.52
RSI43.10
Earnings Daten/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements